Professor
Mary Gospodarowicz
MD, FRCPC, FRCR(Hon), FASCO
Location
Princess Margaret Cancer Centre
Address
610 University Avenue, Toronto, Ontario Canada M5G 2M9
Clinical Interests
Global cancer, Cancer staging and prognostic factors, Clinical trials, Lymphoma
Appointment Status
Primary
Accepting
Please contact Faculty Member for more information
Qualification
- MD, University of Toronto
- FRCPC, Radiation Oncology
- FRCR(Hon), Honorary Fellow of the Royal College of Radiologists, UK
Professional Memberships
- FASCO, Fellow of the American Society of Clinical Oncology (ASCO)
Research Synopsis
- NCIC Clinical Trials Group
- PR.3-Phase III trial of hormone therapy vs. hormones plus pelvic RT in T3N0M0 prostate cancer
- PR.7 – Phase III trial of intermittent vs. continuous hormone therapy in prostate cancer with biochemical progression after RT
- Phase II study of CMT in primary testicular lymphoma, International Extranodal Lymphoma Group
- PMH – Image guided radiotherapy
Appointments
- Consultant Staff, Princess Margaret Hospital/University Health Network
- Professor, Department of Radiation Oncology, University of Toronto
- Chair, Prognostic Factors and TNM Process Task Force, International Union Against Cancer (UICC)
- Member, Board of Directors, International Extranodal Study Group
- Member, Board of Directors, City Cancer Challenge Foundation